
Dr. Reddy's Laboratories Limited RDY
€ 11.73
-0.22%
Quartalsbericht 2022-Q1
hinzugefügt 27.06.2022
Dr. Reddy's Laboratories Limited Betriebszyklus 2011-2026 | RDY
Betriebszyklus Jährlich Dr. Reddy's Laboratories Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 279 | - | - | 167 | 150 | 148 | 155 | - | - | 170 |
Alle Zahlen in INR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 279 | 148 | 178 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
408 | $ 9.33 | 1.41 % | $ 603 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.87 | -2.13 % | $ 6.4 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
332 | $ 22.38 | 0.81 % | $ 3.71 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Galapagos NV
GLPG
|
149 | $ 28.15 | 1.04 % | $ 2.69 B | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.22 | 3.92 % | $ 6.83 B | ||
|
Harmony Biosciences Holdings
HRMY
|
49.3 | $ 30.95 | -0.34 % | $ 1.78 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
ImmuCell Corporation
ICCC
|
232 | $ 8.43 | -0.12 % | $ 76.1 M | ||
|
Incyte Corporation
INCY
|
145 | $ 98.55 | -0.55 % | $ 19.2 B | ||
|
InMed Pharmaceuticals
INM
|
313 | $ 0.71 | 1.27 % | $ 1.74 M | ||
|
Innoviva
INVA
|
24.6 | $ 22.97 | -0.35 % | $ 1.55 B | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Jaguar Health
JAGX
|
964 | $ 7.34 | -6.79 % | $ 17.1 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
KalVista Pharmaceuticals
KALV
|
213 | $ 26.68 | 0.02 % | $ 1.44 B | ||
|
Kamada Ltd.
KMDA
|
269 | $ 8.16 | 0.68 % | $ 260 M | ||
|
Krystal Biotech
KRYS
|
109 | $ 260.24 | 0.11 % | $ 7.53 B | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
77.8 | $ 220.06 | -2.13 % | $ 4.02 B | ||
|
Liquidia Corporation
LQDA
|
65.5 | $ 38.41 | 0.67 % | $ 3.31 B | ||
|
Aquestive Therapeutics
AQST
|
223 | $ 4.08 | 0.62 % | $ 436 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
291 | $ 23.15 | 3.49 % | $ 2.95 B |